Court watchers weren’t shocked when Reed O’Connor, a U.S. district judge in Texas, ruled the Affordable Care Act invalid. Critics say he usually sides with Republicans on ideological cases.
Category: Health Insurance
Orphan drug exclusivity resulting in on-market drug prices rising more slowly than common drugs
Adding an orphan indication to an on-market drug didn’t correlate with a higher-than-average price increase.
Blockchain in the revenue cycle: What healthcare needs to succeed
Stakeholder participation, real-time transparency and emerging use cases will likely help blockchain permeate healthcare over the next several years.
5 Ways Nixing The Affordable Care Act Could Upend The Entire Health System
There could be a long legal struggle ahead over the decision by a judge in Texas to invalidate the federal health law. But if his decision stands, it would have long-lasting effects on health care from insurance coverage to Medicare payments to privacy protections.
Why The U.S. Remains The World’s Most Expensive Market For ‘Biologic’ Drugs
Biologic drugs, made from living organisms, are big moneymakers partly because they have little competition from “biosimilars.” It’s a very different story in Europe.
Cigna, Express Scripts merger to close Thursday
The integration of insurer and pharmacy benefit manager follows that of CVS Health and Aetna.
Pagosa Springs Medical Center settles with OCR over hospital’s failure to terminate former employee’s access to PHI
A complaint said a former PSMC employee continued to have remote access to PSMC’s web-based scheduling calendar even after separation of employment.
Medicare diabetes patients file class action lawsuit against HHS Secretary Alex Azar
Diabetic patients on Medicare have filed a class action lawsuit against …
Vast majority of physicians say data reporting detracting from satisfaction in their work
The Physician Misery Index has increased from 3.78 to 3.94 since 2015 despite increasing awareness of the prevalence of burnout.
Pharma giants Pfizer and GlaxoSmithKline to create joint consumer healthcare business
GSK plans to spin off the newly-combined entity after the deal closes; new company to operate under GSK Consumer Healthcare name.
